Amgen Future Growth
Future criteria checks 4/6
Amgen is forecast to grow earnings and revenue by 23.6% and 2.9% per annum respectively. EPS is expected to grow by 25.3% per annum. Return on equity is forecast to be 240.8% in 3 years.
Key information
23.6%
Earnings growth rate
25.3%
EPS growth rate
| Biotechs earnings growth | 29.1% |
| Revenue growth rate | 2.9% |
| Future return on equity | 240.8% |
| Analyst coverage | Good |
| Last updated | 08 Aug 2024 |
Recent future growth updates
Recent updates
Amgen Inc. Just Missed EPS By 46%: Here's What Analysts Think Will Happen Next
Aug 09
Amgen: Shows Why Dividend Investing Is Getting Tougher
Aug 07Amgen (NASDAQ:AMGN) Takes On Some Risk With Its Use Of Debt
Jul 26The Price Is Right For Amgen Inc. (NASDAQ:AMGN)
Jul 11Amgen: An Emerging GLP-1 Play, Modest Mid-Teens P/E With Strong Momentum
Jul 05Amgen: You Haven't Seen Anything Yet
Jun 17Amgen Is A Fantastic Dividend Growth Stock With A Weight-Loss Wild Card
Jun 04Amgen Stock: Poised To Break Out (Technical Analysis)
May 21Is Amgen Inc. (NASDAQ:AMGN) Trading At A 41% Discount?
May 04Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet
May 01Amgen: The Giant With An Impressive Pipeline
Apr 15Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Apr 01Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock
Mar 31Amgen Will Benefit From Increased Medical Spending
Mar 12Amgen: A Good Dividend Growth Stock For The Watch List
Mar 04Amgen's (NASDAQ:AMGN) Shareholders May Want To Dig Deeper Than Statutory Profit
Feb 21Pinning Down Amgen Inc.'s (NASDAQ:AMGN) P/E Is Difficult Right Now
Feb 16Amgen: Weight Loss Drug Candidate Debate A Red Herring - Buying The Dip Advisable
Feb 08Amgen: Accelerating The Business And Dividend Growth
Jan 29Is Amgen Inc. (NASDAQ:AMGN) Trading At A 44% Discount?
Jan 29Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks
Jan 22Is Amgen (NASDAQ:AMGN) A Risky Investment?
Dec 28Here's Why Amgen (NASDAQ:AMGN) Has Caught The Eye Of Investors
Dec 13Are Investors Undervaluing Amgen Inc. (NASDAQ:AMGN) By 46%?
Oct 23Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Sep 22Do Amgen's (NASDAQ:AMGN) Earnings Warrant Your Attention?
Sep 04Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.13
Aug 05Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 34,891 | 7,009 | 12,715 | 13,595 | 21 |
| 12/31/2025 | 34,210 | 6,002 | 12,436 | 13,177 | 26 |
| 12/31/2024 | 33,184 | 3,494 | 16,824 | 15,167 | 26 |
| 6/30/2024 | 30,934 | 3,130 | 5,481 | 6,446 | N/A |
| 3/31/2024 | 29,532 | 3,763 | 7,098 | 8,096 | N/A |
| 12/31/2023 | 28,190 | 6,717 | 7,359 | 8,471 | N/A |
| 9/30/2023 | 26,833 | 7,566 | 9,379 | 10,582 | N/A |
| 6/30/2023 | 26,582 | 7,979 | 9,685 | 10,800 | N/A |
| 3/31/2023 | 26,190 | 7,917 | 7,531 | 8,621 | N/A |
| 12/31/2022 | 26,323 | 6,552 | 8,785 | 9,721 | N/A |
| 9/30/2022 | 26,330 | 6,835 | 8,997 | 9,880 | N/A |
| 6/30/2022 | 26,384 | 6,576 | 8,355 | 9,320 | N/A |
| 3/31/2022 | 26,316 | 5,723 | 8,417 | 9,321 | N/A |
| 12/31/2021 | 25,979 | 5,893 | 8,381 | 9,261 | N/A |
| 9/30/2021 | 25,767 | 5,609 | 7,840 | 8,606 | N/A |
| 6/30/2021 | 25,484 | 5,746 | 8,897 | 9,556 | N/A |
| 3/31/2021 | 25,164 | 7,085 | 9,835 | 10,467 | N/A |
| 12/31/2020 | 25,424 | 7,264 | 9,889 | 10,497 | N/A |
| 9/30/2020 | 24,987 | 7,352 | 10,235 | 10,858 | N/A |
| 6/30/2020 | 24,301 | 7,299 | 10,209 | 10,867 | N/A |
| 3/31/2020 | 23,966 | 7,675 | 8,795 | 9,439 | N/A |
| 12/31/2019 | 23,362 | 7,842 | 8,532 | 9,150 | N/A |
| 9/30/2019 | 23,395 | 8,067 | 9,175 | 9,830 | N/A |
| 6/30/2019 | 23,562 | 7,958 | 9,070 | 9,726 | N/A |
| 3/31/2019 | 23,750 | 8,075 | 9,715 | 10,414 | N/A |
| 12/31/2018 | 23,747 | 8,394 | 10,558 | 11,296 | N/A |
| 9/30/2018 | 23,319 | 2,202 | 10,448 | 11,114 | N/A |
| 6/30/2018 | 23,188 | 2,364 | 10,642 | 11,295 | N/A |
| 3/31/2018 | 22,939 | 2,219 | N/A | 11,519 | N/A |
| 12/31/2017 | 22,849 | 1,979 | N/A | 11,177 | N/A |
| 9/30/2017 | 23,012 | 8,178 | N/A | 11,265 | N/A |
| 6/30/2017 | 23,050 | 8,174 | N/A | 10,473 | N/A |
| 3/31/2017 | 22,928 | 7,893 | N/A | 10,824 | N/A |
| 12/31/2016 | 22,991 | 7,722 | N/A | 10,354 | N/A |
| 9/30/2016 | 22,562 | 7,587 | N/A | 9,327 | N/A |
| 6/30/2016 | 22,474 | 7,433 | N/A | 9,557 | N/A |
| 3/31/2016 | 22,156 | 7,216 | N/A | 10,164 | N/A |
| 12/31/2015 | 21,662 | 6,939 | N/A | 9,731 | N/A |
| 9/30/2015 | 21,457 | 6,433 | N/A | 10,103 | N/A |
| 6/30/2015 | 20,765 | 5,814 | N/A | 9,952 | N/A |
| 3/31/2015 | 20,575 | 5,708 | N/A | 8,895 | N/A |
| 12/31/2014 | 20,063 | 5,158 | N/A | 8,952 | N/A |
| 9/30/2014 | 19,743 | 4,885 | N/A | 7,945 | N/A |
| 6/30/2014 | 19,460 | 5,009 | N/A | 7,011 | N/A |
| 3/31/2014 | 18,959 | 4,720 | N/A | 6,384 | N/A |
| 12/31/2013 | 18,676 | 5,081 | N/A | 6,291 | N/A |
| 9/30/2013 | 17,980 | 4,848 | N/A | 5,268 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AMGN's forecast earnings growth (23.6% per year) is above the savings rate (2.5%).
Earnings vs Market: AMGN's earnings (23.6% per year) are forecast to grow faster than the US market (14.7% per year).
High Growth Earnings: AMGN's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AMGN's revenue (2.9% per year) is forecast to grow slower than the US market (8.5% per year).
High Growth Revenue: AMGN's revenue (2.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AMGN's Return on Equity is forecast to be very high in 3 years time (240.8%).